The therapeutic efficacy of thiabendazole for helminthic infections in man; a literature review.
D001196:Ascariasis / Q000188:drug therapy; D001598:Bephenium Compounds / Q000627:therapeutic use; D004225:Dithiazanine / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy*; D006604:Hexylresorcinol / Q000627:therapeutic use; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D007815:Larva Migrans / Q000188:drug therapy; D010123:Oxyuriasis / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D012552:Schistosomiasis / Q000188:drug therapy; D013322:Strongyloidiasis / Q000188:drug therapy; D013622:Taeniasis / Q000188:drug therapy; D013750:Tetrachloroethylene / Q000627:therapeutic use; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use*; D014235:Trichinellosis / Q000188:drug therapy; D014252:Trichostrongyloidiasis / Q000188:drug therapy; D014257:Trichuriasis / Q000188:drug therapy*
D001598:Bephenium Compounds; D010879:Piperazines; D011725:Pyridines; D004225:Dithiazanine; D013827:Thiabendazole; D006604:Hexylresorcinol; D013750:Tetrachloroethylene